相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High Levels of Nuclear MYC Protein Predict the Presence of MYC Rearrangement in Diffuse Large B-cell Lymphoma
Tina Marie Green et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP
Mamta Gupta et al.
BLOOD (2012)
Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge
Santiago Montes-Moreno et al.
LEUKEMIA & LYMPHOMA (2012)
Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
Michael J. Kluk et al.
PLOS ONE (2012)
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Gonzalo Gutierrez-Garcia et al.
BLOOD (2011)
STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
Anna Scuto et al.
CANCER RESEARCH (2011)
Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma
Kengo Takeuchi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas
Gustavo Tapia et al.
HISTOPATHOLOGY (2011)
Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements
Min Shi et al.
HUMAN PATHOLOGY (2011)
High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma
Z. L. Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Anaplastic lymphoma kinase in human cancer
Antonella Barreca et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Inhibition of Anaplastic Lymphoma Kinase (ALK) Activity Provides a Therapeutic Approach for CLTC-ALK-Positive Human Diffuse Large B Cell Lymphomas
Leandro Cerchietti et al.
PLOS ONE (2011)
Altered Subcellular Localization of c-Myc Protein Identifies Aggressive B-cell Lymphomas Harboring a c-MYC Translocation
Marianna B. Ruzinova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas
Kristopher A. Sarosiek et al.
BLOOD (2010)
Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
Santiago Montes-Moreno et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions
Katrien Van Roosbroeck et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features
Lekidelu Taddesse-Heath et al.
MODERN PATHOLOGY (2010)
NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma
Seong-Su Han et al.
MOLECULAR CANCER (2010)
Activation of the Endoplasmic Reticulum Stress-Associated Transcription Factor X Box-Binding Protein-1 Occurs in a Subset of Normal Germinal-Center B Cells and in Aggressive B-Cell Lymphomas with Prognostic Implications
Olga Balague et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Inhibition of ALK Signaling for Cancer Therapy
Yael P. Mosse et al.
CLINICAL CANCER RESEARCH (2009)
Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion
Shuji Momose et al.
HUMAN PATHOLOGY (2009)
Anaplastic Lymphoma Kinase-Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor Prognosis
Camille Laurent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature
Brady Beltran et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
ALK-positive Diffuse Large B-cell Lymphoma With the t(2;17)(p23;q23)
Da Zhang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma
Lloyd T. Lam et al.
BLOOD (2008)
ALK-positive diffuse large B-cell lymphoma: report of three cases
Hyoun Wook Lee et al.
HEMATOLOGICAL ONCOLOGY (2008)
STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation
Sean A. Diehl et al.
JOURNAL OF IMMUNOLOGY (2008)
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
B. Belinda Ding et al.
BLOOD (2008)
Germinal centres: role in B-cell physiology and malignancy
Ulf Klein et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3′ ALK gene insertion to chromosome 4 q22-24
Dariusz Stachurski et al.
HUMAN PATHOLOGY (2007)
ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature
Kaaren K. Reichard et al.
MODERN PATHOLOGY (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue
Roland A. Ventura et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
ALK-positive diffuse large B-cell lymphoma
H Bubala et al.
PEDIATRIC BLOOD & CANCER (2006)
ALK-Positive plasmablastic B-Cell lymphoma with the clathrin-ALK gene rearrangement
G Isimbaldi et al.
PEDIATRIC BLOOD & CANCER (2006)
ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas
S Gesk et al.
LEUKEMIA (2005)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathirin-ALK rearrangement
DT McManus et al.
HUMAN PATHOLOGY (2004)
A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation
P Adam et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript:: report of 2 cases
M Onciu et al.
BLOOD (2003)
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements:: report of 6 cases
RD Gascoyne et al.
BLOOD (2003)
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
P De Paepe et al.
BLOOD (2003)
ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC)
N Chikatsu et al.
MODERN PATHOLOGY (2003)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-myc expression in pediatric anaplastic large cell lymphomas
EA Raetz et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
A Zamo et al.
ONCOGENE (2002)
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
H Avet-Loiseau et al.
BLOOD (2001)
Plasma cell differentiation requires the transcription factor XBP-1
AM Reimold et al.
NATURE (2001)
分享论文
